Stay updated with breaking news from Immunization Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The positive vote is based on compelling scientific evidence presented, including Phase 3 efficacy and safety data in pregnant individuals and their infants FDA decision expected in August... | May 18, 2023
The positive vote is based on compelling scientific evidence presented, including Phase 3 efficacy and safety data in pregnant individuals and their infants FDA decision expected in August
The trial did not meet the second primary efficacy endpoint of medically attended respiratory syncytial virus-associated lower respiratory tract illness.
Three major respiratory viruses—respiratory syncytial virus, seasonal influenza, and COVID-19—are surging at once, prompting a determined scientific response.
Southern California’s Orange County Health Department this month declared a local health emergency over concerns around the rising number of pediatric cases of Respiratory Syncytial Virus (RSV). [...]